Bavituximab

• Description :

  Bavituximab (Anti-Human Phosphatidylserine Recombinant Antibody) is a monoclonal antibody targeting phosphatidylserine (PS) with vascular targeting and immunomodulatory properties, capable of reactivating anti-tumor immunity to inhibit tumor growth. It has anti-cancer activity and is frequently used with Paclitaxel and Carboplatin in non-small cell lung cancer studies.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Molecular Formula :

  ——

• Notes :

  Research use only, not for human use.

• Receptor :

  Others

• CAS Number :

  648904-28-3